Flexion Therapeutics, Inc.
FLXN
FLXN was delisted on the 18th of November, 2021.
129 hedge funds and large institutions have $426M invested in Flexion Therapeutics, Inc. in 2019 Q1 according to their latest regulatory filings, with 25 funds opening new positions, 48 increasing their positions, 32 reducing their positions, and 21 closing their positions.
50% more repeat investments, than reductions
Existing positions increased: 48 | Existing positions reduced: 32
19% more first-time investments, than exits
New positions opened: 25 | Existing positions closed: 21
3% more funds holding
Funds holding: 125 → 129 (+4)
4% more capital invested
Capital invested by funds: $410M → $426M (+$16.3M)
3% more call options, than puts
Call options by funds: $1.64M | Put options by funds: $1.59M
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
MVP
Miller Value Partners
Sarasota,
Florida
|
+$13.3M |
| 2 |
GS
Gagnon Securities
New York
|
+$5.81M |
| 3 |
CC
Clearline Capital
New York
|
+$5.64M |
| 4 |
CAM
Cortina Asset Management
Milwaukee,
Wisconsin
|
+$4.63M |
| 5 |
KCM
Kingdon Capital Management
New York
|
+$4.01M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Wells Fargo
San Francisco,
California
|
-$24.4M |
| 2 |
GGHC
Gilder Gagnon Howe & Co
New York
|
-$13.7M |
| 3 |
Point72 Asset Management
Stamford,
Connecticut
|
-$13.5M |
| 4 |
CC
Carlson Capital
Dallas,
Texas
|
-$6.27M |
| 5 |
RPAM
Rhenman & Partners Asset Management
Stockholm,
Sweden
|
-$5.21M |
FLXN Hedge Fund Activity: Q1 2019 in Review
129 of the 4,633 institutional investors tracked by Wall St. Rank reported a position in Flexion Therapeutics, Inc. (FLXN) for Q1 2019, worth a combined $426M — up 4% from $410M a quarter earlier.
Buyers outnumbered sellers: 25 funds opened new FLXN positions and 21 closed out — a net gain of 4 holders — while 48 added to existing stakes and 32 trimmed.
The largest buyer was Miller Value Partners, adding an estimated $13.3M. The largest seller was Wells Fargo, cutting an estimated $24.4M.
- 129 institutional investors held Flexion Therapeutics, Inc. (FLXN) as of Q1 2019, up from 125 in Q4 2018.
- Funds reported $426M of Flexion Therapeutics, Inc. stock for Q1 2019, up 4% quarter-over-quarter.
- 25 funds opened new Flexion Therapeutics, Inc. positions in Q1 2019 and 21 closed out, a net change of +4 holders.
- The largest Flexion Therapeutics, Inc. buyer in Q1 2019 was Miller Value Partners, an estimated $13.3M added.
- The largest Flexion Therapeutics, Inc. seller in Q1 2019 was Wells Fargo, an estimated $24.4M sold.
Based on aggregated 13F filings for Q1 2019.